Evaluating and Pricing Health Insurance in Lower-income Countries: A Field Experiment in India
Universal health coverage is a widely shared goal across lower-income countries. We conducted a large-scale, 4-year trial that randomized premiums and subsidies for India’s first national, public hospital insurance program, called RSBY. We find substantial demand (∼ 60% uptake) even when consumers were charged a price equal to the premium the government paid for insurance. We also find substantial adverse selection into insurance at positive prices. Insurance enrollment increases insurance utilization, partly due to spillovers from use of insurance by neighbors. However, healthcare utilization does not rise substantially, suggesting the primary benefit of insurance is financial. Many enrollees attempted to use insurance but failed, suggesting that learning is critical to the success of public insurance. We find very few statistically significant impacts of insurance access or enrollment on health. Because there is substantial willingness-to- pay for insurance, and given how distortionary it is to raise revenue in the Indian context, we calculate that our sample population should be charged a premium for RSBY between 67-95% of average costs (INR 528-1052, $30-60) rather than a zero premium to maximize the marginal value of public funds.
-
-
Copy CitationAnup Malani, Cynthia Kinnan, Gabriella Conti, Kosuke Imai, Morgen Miller, Shailender Swaminathan, Alessandra Voena, and Bartosz Woda, "Evaluating and Pricing Health Insurance in Lower-income Countries: A Field Experiment in India," NBER Working Paper 32239 (2024), https://doi.org/10.3386/w32239.Download Citation
-
-
Related
Working Groups
More from the NBER
In addition to working papers, the NBER disseminates affiliates’ latest findings through a range of free periodicals—the NBER Reporter, the NBER Digest, the Bulletin on Health, the Bulletin on the Economics of Alzheimer's, and the Bulletin on Entrepreneurship—as well as research spotlights, lectures, and panel videos.
